Back to Search
MARY AMON, M.D.
M.D.
Family Medicine Physician
NPI: 1518902998IndividualAccepts Medicare
Specialties, Licenses & Credentials
CMS Specialties
PrimaryFAMILY PRACTICE
Education
UNIVERSITY OF MINNESOTA MEDICAL SCHOOL
Class of 1991
Research & Publications (20)
Erythropoietin reduces necrosis in critically ischemic myocutaneous tissue by protecting nutritive perfusion in a dose-dependent manner.
PMID 19303985·Surgery·2009
7-preclinical
Fluorinated non-imidazole histamine H3 receptor antagonists.
PMID 19286376·Bioorg Med Chem Lett·2009
4-observational
An old dream revitalised: preconditioning strategies to protect surgical flaps from critical ischaemia and ischaemia-reperfusion injury.
PMID 18166506·J Plast Reconstr Aesthet Surg·2008
6-review
Therapeutic application of transmembrane T and natural killer cell receptor peptides.
PMID 19065794·Adv Exp Med Biol·2008
6-review
Kinetic and conformational properties of a novel T-cell antigen receptor transmembrane peptide in model membranes.
PMID 18240131·J Pept Sci·2008
8-other
Ischemia-induced up-regulation of heme oxygenase-1 protects from apoptotic cell death and tissue necrosis.
PMID 18262556·J Surg Res·2008
7-preclinical
Hypothesis: TCR signal transduction--A novel tri-modular signaling system.
PMID 17915329·Mol Immunol·2008
7-preclinical
Highly potent fluorescence-tagged nonimidazole histamine H3 receptor ligands.
PMID 17361979·ChemMedChem·2007
8-other
Selective blockade of endothelin-B receptor improves survival of critically perfused musculocutaneous flaps.
PMID 17380348·Langenbecks Arch Surg·2007
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 502 2ND ST SW
WILLMAR, MN 56201 - Phone
- (320) 235-7232
Quick Facts
- NPI
- 1518902998
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 35
- Publications
- 20
Are you this provider?
Claim Your Profile